Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Carcinomas that develop in the pancreatic islets of transgenic mice expressing the SV40 T-antigens (Tag) under transcriptional control of the rat insulin II promoter (RIP) progress through well-characterized stages that are similar to aspects of human tumor progression, including hyperplastic growth, increased angiogenesis and reduced apoptosis. The latter two stages have been associated with recurrent loss of heterozygosity (LOH) and reduced genome copy number on chromosomes 9 (LOH9) and 16 (LOH16), aberrations which we believe contribute to these phenotypes. Earlier analyses localized LOH9 to approximately 3 Mb and LOH16 to approximately 30 Mb (both syntenic with human 3q21-q25) but were limited by low throughput and a lack of informative polymorphic markers. Here we show that comparative genomic hybridization to DNA microarrays (array CGH) overcomes these limitations by allowing efficient, genome-wide analyses of relative genome copy number. The CGH arrays used in these experiments carried BACs distributed at 2-20-MB intervals across the mouse genome and at higher density in regions of interest. Using array CGH, we further narrowed the loci for LOH9 and LOH16 and defined new or previously unappreciated recurrent regions of copy-number decrease on chromosomes 6, 8 and 14 (syntenic with human chromosomes 12p11-p13, 16q24.3 and 13q11-q32, respectively) and regions of copy-number increase on chromosomes 2 and 4 (syntenic to human chromosomes 20q13.2 and 1p32-p36, respectively). Our analyses of human genome sequences syntenic to these regions suggest that CYP24, PFDN4, STMN1, CDKN1B, PPP2R3 and FSTL1 are candidate oncogenes or tumor-suppressor genes. We also show that irradiation and genetic background influence the spectrum of aberrations present in these tumors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conventional mouse models driven by activated oncogenes or loss of tumor suppressor genes exhibited fewer focal CNAs, instead showing genomic profiles characterized by gain or loss of whole chromosomes (114-118).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [114]
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Pinkel, D., Segraves, R., Sudar, D., Clark, S., Poole, I., Kowbel, D., Collins, C., Kuo, W.-L., Chen, C., Zhai, Y., et al. (1998) · Nature Genetics · doi:10.1038/2524 · Cited by 2,240
Self-citationGenome-wide analysis of DNA copy-number changes using cDNA microarrays
Pollack, J. R., Perou, C. M., Alizadeh, A. A., Eisen, M. B., Pergamenschikov, A., Williams, C. F., Jeffrey, S. S., Botstein, D., & Brown, P. O. (1999) · Nature Genetics · doi:10.1038/12640 · Cited by 1,423
Telenius, H., Carter, N. P., Bebb, C. E., Nordenskjo¨ld, M., Ponder, B. A. J., & Tunnacliffe, A. (1992) · Genomics · doi:10.1016/0888-7543(92)90147-k · Cited by 1,418
Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances
Solinas-Toldo, S., Lampel, S., Stilgenbauer, S., Nickolenko, J., Benner, A., Döhner, H., Cremer, T., & Lichter, P. (1997) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199712)20:4<399::aid-gcc12>3.0.co;2-i · Cited by 1,002
The murine gene p27Kip1 is haplo-insufficient for tumour suppression
Fero, M. L., Randel, E., Gurley, K. E., Roberts, J. M., & Kemp, C. J. (1998) · Nature · doi:10.1038/24179 · Cited by 784
Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene
Albertson, D. G., Ylstra, B., Segraves, R., Collins, C., Dairkee, S. H., Kowbel, D., Kuo, W.-L., Gray, J. W., & Pinkel, D. (2000) · Nature Genetics · doi:10.1038/75985 · Cited by 589
Self-citationPrefoldin, a Chaperone that Delivers Unfolded Proteins to Cytosolic Chaperonin
Vainberg, I. E., Lewis, S. A., Rommelaere, H., Ampe, C., Vandekerckhove, J., Klein, H. L., & Cowan, N. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81446-4 · Cited by 565
Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene.
Efrat, S., Linde, S., Kofod, H., Spector, D., Delannoy, M., Grant, S., Hanahan, D., & Baekkeskov, S. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9037 · Cited by 515
Self-citation
Cited by
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J.-P., Tong, F., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,188
“Scanning arrays were comprised of 2464 BACs selected at approximately megabase intervals along the genome as described previously (Hodgson et al., 2001; Snijders et al., 2001).”
MethodSelf-citationCircular binary segmentation for the analysis of array-based DNA copy number data
Olshen, A. B., Venkatraman, E. S., Lucito, R., & Wigler, M. (2004) · Biostatistics · doi:10.1093/biostatistics/kxh008 · Cited by 2,325
“A model-based approach for array copy number data is due to Hodgson et al. (2001).”
MethodInduction of tumors in mice by genomic hypomethylation
Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083558 · Cited by 1,499
Self-citationGenomic and transcriptional aberrations linked to breast cancer pathophysiologies
Chin, K., DeVries, S., Fridlyand, J., Spellman, P. T., Roydasgupta, R., Kuo, W.-L., Lapuk, A., Neve, R. M., Qian, Z., Ryder, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.009 · Cited by 1,317
“We assessed genome copy number using BAC array CGH (Hodgson et al., 2001; Pinkel et al., 1998; Snijders et al., 2001; Solinas-Toldo et al., 1997) and gene expression profiles using Affymetrix U133A arrays (Ramaswamy et al., 2003; Reyal et al., 2005) in breast tumors from a cohort of patients…”
InfluentialSelf-citationTelomeres and telomerase in cancer
Artandi, S. E., & DePinho, R. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp268 · Cited by 823
Chromosome aberrations in solid tumors
Albertson, D. G., Collins, C., McCormick, F., & Gray, J. W. (2003) · Nature Genetics · doi:10.1038/ng1215 · Cited by 812
Self-citationOta, A., Tagawa, H., Karnan, S., Tsuzuki, S., Karpas, A., Kira, S., Yoshida, Y., & Seto, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3773 · Cited by 724
Pelengaris, S., Khan, M., & Evan, G. I. (2002) · Cell · doi:10.1016/s0092-8674(02)00738-9 · Cited by 626
Nannya, Y., Sanada, M., Nakazaki, K., Hosoya, N., Wang, L., Hangaishi, A., Kurokawa, M., Chiba, S., Bailey, D. K., Kennedy, G. C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0465 · Cited by 639
Array comparative genomic hybridization and its applications in cancer
Pinkel, D., & Albertson, D. G. (2005) · Nature Genetics · doi:10.1038/ng1569 · Cited by 585
Self-citationThe genetics and genomics of cancer
Balmain, A., Gray, J., & Ponder, B. (2003) · Nature Genetics · doi:10.1038/ng1107 · Cited by 573
Self-citationShaw-Smith, C., Redon, R., Rickman, L., Rio, M., Willatt, L., Fiegler, H., Firth, H., Sanlaville, D., Winter, R., Colleaux, L., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.017731 · Cited by 513
Fiegler, H., Carr, P., Douglas, E. J., Burford, D. C., Hunt, S., Smith, J., Vetrie, D., Gorman, P., Tomlinson, I. P. M., & Carter, N. P. (2003) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10155 · Cited by 465
“Snijders et al. (2001) used the approach of linker adapter PCR, whereas Hodgson et al. (2001) used degenerate oligonucleotide-primed PCR (DOPPCR) with an amine-modified version of the standard DOP-PCR primer 6MW (Telenius et al., 1992a,b) for mouse arrays.”
MethodA comparison study: applying segmentation to array CGH data for downstream analyses
Willenbrock, H., & Fridlyand, J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti677 · Cited by 463
The melanocyte differentiation program predisposes to metastasis after neoplastic transformation
Gupta, P. B., Kuperwasser, C., Brunet, J.-P., Ramaswamy, S., Kuo, W.-L., Gray, J. W., Naber, S. P., & Weinberg, R. A. (2005) · Nature Genetics · doi:10.1038/ng1634 · Cited by 439
Self-citationComparative analysis of algorithms for identifying amplifications and deletions in array CGH data
Lai, W. R., Johnson, M. D., Kucherlapati, R., & Park, P. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti611 · Cited by 402
“In another study, a simple maximum likelihood method was used to fit a mixture of three Gaussian distributions corresponding to gain, loss and normal regions (Hodgson et al., 2001).”
MethodHigh-Resolution Analysis of DNA Copy Number Using Oligonucleotide Microarrays
Bignell, G. R., Huang, J., Greshock, J., Watt, S., Butler, A., West, S., Grigorova, M., Jones, K. W., Wei, W., Stratton, M. R., et al. (2004) · Genome Research · doi:10.1101/gr.2012304 · Cited by 394
“DNA was labeled (random prime labeling kit, Invitrogen) and hybridized together with Cot-1 DNA for 48–72 h at 37°C. Slides were washed as described by Hodgson et al. (2001) and scanned using the Affymetrix 428 microarray scanner.”
MethodInfluentialChromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers
Maser, R. S., Choudhury, B., Campbell, P. J., Feng, B., Wong, K.-K., Protopopov, A., O’Neil, J., Gutierrez, A., Ivanova, E., Perna, I., et al. (2007) · Nature · doi:10.1038/nature05886 · Cited by 377
Genomic microarrays in human genetic disease and cancer
Albertson, D. G., & Pinkel, D. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg261 · Cited by 371
“(2002) Additional patient with del(12)(q21.”
Self-citationComparative genomic hybridization using oligonucleotide microarrays and total genomic DNA
Barrett, M. T., Scheffer, A., Ben-Dor, A., Sampas, N., Lipson, D., Kincaid, R., Tsang, P., Curry, B., Baird, K., Meltzer, P. S., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407979101 · Cited by 366
Cancer Modeling in the Modern Era
Van Dyke, T., & Jacks, T. (2002) · Cell · doi:10.1016/s0092-8674(02)00621-9 · Cited by 358
“…refined, and addivided an important tool with which to understand these tional regions of copy number changes detected, using dynamics, though much more work is needed before array-based comparative genomic hybridization analyunifying principles are fully understood. sis (Hodgson et al., 2001).”
BackgroundHidden Markov models approach to the analysis of array CGH data
Fridlyand, J., Snijders, A. M., Pinkel, D., Albertson, D. G., & Jain, A. N. (2004) · Journal of Multivariate Analysis · doi:10.1016/j.jmva.2004.02.008 · Cited by 349
“A variety of cytogenetic and more recently array-based [6,13,19] analytic methods have revealed a wide range in the number and types of DNA copy number aberrations present in human and murine tumors.”
BackgroundSelf-citationAmplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer
Guan, Y., Kuo, W.-L., Stilwell, J. L., Takano, H., Lapuk, A. V., Fridlyand, J., Mao, J.-H., Yu, M., Miller, M. A., Santos, J. L., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2882 · Cited by 347
“Relative genome number was assessed in the 30 ovarian cell lines using array CGH with three BAC arrays as described previously (12, 13).”
BackgroundMethodSelf-citationMaking sense of cancer genomic data
Chin, L., Hahn, W. C., Getz, G., & Meyerson, M. (2011) · Genes & Development · doi:10.1101/gad.2017311 · Cited by 336
A method for calling gains and losses in array CGH data
Wang, P., Kim, Y., Pollack, J., Narasimhan, B., & Tibshirani, R. (2005) · Biostatistics · doi:10.1093/biostatistics/kxh017 · Cited by 307
“In another paper (Hodgson et al., 2001), the distribution of the log ratio of the DNA copy numbers was treated as a mixture of three Gaussian distributions and an MLE solution was implemented.”
MethodConditional mouse models of sporadic cancer
Jonkers, J., & Berns, A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc777 · Cited by 294
MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer
Olson, P., Lu, J., Zhang, H., Shai, A., Chun, M. G., Wang, Y., Libutti, S. K., Nakakura, E. K., Golub, T. R., & Hanahan, D. (2009) · Genes & Development · doi:10.1101/gad.1820109 · Cited by 260
Self-citationOf Mice and MEN1: Insulinomas in a Conditional Mouse Knockout
Crabtree, J. S., Scacheri, P. C., Ward, J. M., McNally, S. R., Swain, G. P., Montagna, C., Hager, J. H., Hanahan, D., Edlund, H., Magnuson, M. A., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.17.6075-6085.2003 · Cited by 249
“Support for this notion comes from the fact that multiple independent copy number abnormalities have been detected in RIP-Tag tumors by LOH, CGH, and array CGH analyses (8, 17, 26).”
BackgroundSelf-citationVeltman, J. A., Fridlyand, J., Pejavar, S., Olshen, A. B., Korkola, J. E., DeVries, S., Carroll, P. R., Kuo, W. L., Pinkel, D., Albertson, D. G., et al. (2003) · PubMed · Cited by 295
Self-citationTelomere dysfunction provokes regional amplification and deletion in cancer genomes
O'Hagan, R. C., Chang, S., Maser, R. S., Mohan, R., Artandi, S. E., Chin, L., & DePinho, R. A. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00094-6 · Cited by 246
Paci, P., Colombo, T., & Farina, L. (2014) · BMC Systems Biology · doi:10.1186/1752-0509-8-83 · Cited by 237
“PVT1 is the main ceRNA regulator in normal breast PVT1 is a lncRNA that appears to be strongly conserved between mouse and human [49] and amplification of its locus is one of the most frequent events in breast cancer [50].”
BackgroundDOCK4, a GTPase activator, is disrupted during tumorigenesis.
Yajnik, V., Paulding, C., Sordella, R., McClatchey, A. I., Saito, M., Wahrer, D. C. R., Reynolds, P., Bell, D. W., Lake, R., van den Heuvel, S., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00155-7 · Cited by 230
Wang, T.-L., Maierhofer, C., Speicher, M. R., Lengauer, C., Vogelstein, B., Kinzler, K. W., & Velculescu, V. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202610899 · Cited by 219
Li, Z., Yu, T., Morishima, M., Pao, A., LaDuca, J., Conroy, J., Nowak, N., Matsui, S.-I., Shiraishi, I., & Yu, Y. E. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm086 · Cited by 218
Naylor, T. L., Greshock, J., Wang, Y., Colligon, T., Yu, Q., Clemmer, V., Zaks, T. Z., & Weber, B. L. (2005) · Breast Cancer Research · doi:10.1186/bcr1356 · Cited by 212
Sadanandam, A., Wullschleger, S., Lyssiotis, C. A., Grötzinger, C., Barbi, S., Bersani, S., Körner, J., Wafy, I., Mafficini, A., Lawlor, R. T., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0068 · Cited by 207
“We infer that Men1 mutations are not occurring in either IT or MLP subtypes in the RT2 mouse model of PanNET, as evidenced by the lack of detectable copy-number losses by CGH on mouse chromosome 19 where Men1 resides (26, 27).”
Self-citationPreimplantation genetic diagnosis: State of the ART 2011
Harper, J. C., & SenGupta, S. B. (2012) · Human Genetics · doi:10.1007/s00439-011-1056-z · Cited by 210
“Each slide may consist of 100 to 1,000s of clones covering the entire genome that increases the resolution to 100–200 kb (Pinkel et al. 1998; Pollack et al. 1999; Heiskanen et al. 2000; Bruder et al. 2001; Hodgson et al. 2001; Wessendorf et al. 2002).”
Schaeffer, A. J., Chung, J., Heretis, K., Wong, A., Ledbetter, D. H., & Lese Martin, C. (2004) · The American Journal of Human Genetics · doi:10.1086/421250 · Cited by 207
“CGH arrays have been successfully utilized to identify amplifications and deletions in multiple cancer types (Hodgson et al. 2001; Cai et al. 2002; Paris et al. 2003; Schwaenen et al. 2003), and their use in studying constitutional rearrangements is increasing (Veltman et al. 2002; Gunn et al.…”
MethodCOMPARATIVE GENOMIC HYBRIDIZATION
Pinkel, D., & Albertson, D. G. (2005) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.6.080604.162140 · Cited by 203
Self-citationBauer, J., & Bastian, B. C. (2006) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2005.00055.x · Cited by 204
“Comparative genomic hybridization also has been useful in analyzing somatic alterations in cancers developing in mouse models of cancer (48,49).”
BackgroundMoore, L. E., Nickerson, M. L., Brennan, P., Toro, J. R., Jaeger, E., Rinsky, J., Han, S. S., Zaridze, D., Matveev, V., Janout, V., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002312 · Cited by 199
“DNA samples for array CGH were labeled as described previously [48,49].”
MethodUse of targeted array‐based CGH for the clinical diagnosis of chromosomal imbalance: Is less more?
Bejjani, B. A., Saleki, R., Ballif, B. C., Rorem, E. A., Sundin, K., Theisen, A., Kashork, C. D., & Shaffer, L. G. (2005) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30621 · Cited by 195
“Weused a dyereversal strategy on two separate microarrays in which 500 ng of both subject and reference DNAs were labeled (Bio Prime DNA labeling System, Invitrogen) with Cyanine3 (Cy3) or Cyanine5 (Cy5), respectively [Hodgson et al., 2001].”
MethodBorowsky, A. D., Namba, R., Young, L. J. T., Hunter, K. W., Hodgson, J. G., Tepper, C. G., McGoldrick, E. T., Muller, W. J., Cardiff, R. D., & Gregg, J. P. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-2908-5 · Cited by 194
“Array-based comparative genomic hybridization (CGH) was performed essentially as described [21, 22].”
MethodGenome-wide detection of chromosomal imbalances in tumors using BAC microarrays
Cai, W.-W., Mao, J.-H., Chow, C.-W., Damani, S., Balmain, A., & Bradley, A. (2002) · Nature Biotechnology · doi:10.1038/nbt0402-393 · Cited by 191
Wang, N. J., Liu, D., Parokonny, A. S., & Schanen, N. C. (2004) · The American Journal of Human Genetics · doi:10.1086/422854 · Cited by 180
“…comparative genomic hybridization (array CGH) has been used elsewhere to scan for genomic abnormalities at a 1-Mb resolution level, as well as at higher resolutions, for a single chromosome or smaller genomic region (Bruder et al. 2001; Hodgson et al. 2001; Vissers et al. 2003; Yu et al. 2003).”
MethodWhite, S., Kalf, M., Liu, Q., Villerius, M., Engelsma, D., Kriek, M., Vollebregt, E., Bakker, B., van Ommen, G.-J. B., Breuning, M. H., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/341942 · Cited by 180
“Samples were analyzed using a combination of methods described for analysis of MAPH (Armour et al. 2000; Sismani et al. 2001) and array-based comparative genomic hybridization (Hodgson et al. 2001) experiments.”
BackgroundMethodApplication of Microarray Technology in Environmental and Comparative Physiology
Gracey, A. Y., & Cossins, A. R. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142716 · Cited by 166
“Even differences between strains of laboratory mouse (127),Mycobacterium(128), and closely related microbial genomes (129) can be detected in the array-CGH ratios.”
BackgroundDenoising array-based comparative genomic hybridization data using wavelets
Hsu, L. (2005) · Biostatistics · doi:10.1093/biostatistics/kxi004 · Cited by 162
Locke, D. P., Segraves, R., Carbone, L., Archidiacono, N., Albertson, D. G., Pinkel, D., & Eichler, E. E. (2003) · Genome Research · doi:10.1101/gr.1003303 · Cited by 161
“To date, the array CGH technique has been used primarily to assess within-species DNA copy-number variation associated with tumor progression or recurrent structural rearrangements of the human genome (Pinkel et al. 1998; Albertson et al. 2000; Bruder et al. 2001; Hodgson et al. 2001).”
MethodSelf-citationChung, Y.-J., Jonkers, J., Kitson, H., Fiegler, H., Humphray, S., Scott, C., Hunt, S., Yu, Y., Nishijima, I., Velds, A., et al. (2004) · Genome Research · doi:10.1101/gr.1878804 · Cited by 162
“Although mouse BAC arrays have been described previously, they have variable (2–20 Mb) and moderate (3 Mb) resolution (Hodgson et al. 2001; Cai et al. 2002).”
BackgroundMethodInfluentialChing, T.-T., Maunakea, A. K., Jun, P., Hong, C., Zardo, G., Pinkel, D., Albertson, D. G., Fridlyand, J., Mao, J.-H., Shchors, K., et al. (2005) · Nature Genetics · doi:10.1038/ng1563 · Cited by 159
Self-citationSquire, J. A., Pei, J., Marrano, P. M., Beheshti, B., Bayani, J., Lim, G., Moldovan, L., & Zieleńska, M. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10273 · Cited by 159
Molecular Karyotyping: Array CGH Quality Criteria for Constitutional Genetic Diagnosis
Vermeesch, J. R., Melotte, C., Froyen, G., Van Vooren, S., Dutta, B., Maas, N., Vermeulen, S., Menten, B., Speleman, F., De Moor, B., et al. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.4a6436.2005 · Cited by 155
Hodgson, J. G., Yeh, R.-F., Ray, A., Wang, N. J., Smirnov, I., Yu, M., Hariono, S., Silber, J., Feiler, H. S., Gray, J. W., et al. (2009) · Neuro-Oncology · doi:10.1215/15228517-2008-113 · Cited by 149
Self-citationHurst, C. D., Fiegler, H., Carr, P., Williams, S. V., Carter, N. P., & Knowles, M. A. (2004) · Oncogene · doi:10.1038/sj.onc.1207260 · Cited by 149
Ruvolo, P. P. (2016) · BBA Clinical · doi:10.1016/j.bbacli.2016.08.002 · Cited by 143
Bertolino, P., Tong, W., Herrera, P. L., Casse, H., Zhang, C. X., & Wang, Z.-Q. (2003) · PubMed · Cited by 168
Yu, W. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg230 · Cited by 138
“Patient and reference genomic DNAs were labeled by random priming using a BioPrime DNA labeling kit (Invitrogen) and following the described protocol (7) with some modification.”
MethodKurotaki, N., Harada, N., Shimokawa, O., Miyake, N., Kawame, H., Uetake, K., Makita, Y., Kondoh, T., Ogata, T., Hasegawa, T., et al. (2003) · Human Mutation · doi:10.1002/humu.10270 · Cited by 135
“Protocols used here were as described elsewhere [Hodgson et al., 2001].”
MethodThe clinical utility of enhanced subtelomeric coverage in array CGH
Ballif, B. C., Sulpizio, S. G., Lloyd, R. M., Minier, S. L., Theisen, A., Bejjani, B. A., & Shaffer, L. G. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31842 · Cited by 129
“Briefly, a dye-reversal strategy was used on two separate microarrays in which 500 ng of both subject and chromosomally normal human control DNAs were labeled (Bio Prime DNA labeling System, Invitrogen, Carlsbad, CA) with Cyanine 3-dCTP (Cy3; Perkin Elmer, Shelton, CT) or Cyanine 5-dCTP (Cy5; Perkin Elmer), respective…”
MethodThe detection of large deletions or duplications in genomic DNA
Armour, J. A. L., Barton, D. E., Cockburn, D. J., & Taylor, G. R. (2002) · Human Mutation · doi:10.1002/humu.10133 · Cited by 132
“Soon afterward, a paper describing a mouse CGH array experiment [Hodgson et al., 2001] reported modifications and improvements to the original methods of Pinkel et al. [1998].”
MethodHigh resolution microarray comparative genomic hybridisation analysis using spotted oligonucleotides
Carvalho, B., Ouwerkerk, E., Meijer, G. A., & Ylstra, B. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.013029 · Cited by 127
Chin, S.-F., Wang, Y., Thorne, N., Teschendorff, A. E., Pinder, S. E., Vias, M., Naderi, A., Roberts, I., Barbosa‐Morais, N. L., García, M. J., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209985 · Cited by 119
“Nevertheless, only 10% (15/148) of cases had tumor cellularity lower than 40%, which is the threshold for detecting single copy changes (Hodgson et al., 2001).”
BackgroundDefinition of a Critical Region on Chromosome 18 for Congenital Aural Atresia by ArrayCGH
Veltman, J. A., Jonkers, Y., Nuijten, I., Janssen, I., van der Vliet, W., Huys, E., Vermeesch, J., Van Buggenhout, G., Fryns, J.-P., Admiraal, R., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375695 · Cited by 115
“72:1578–1584, 2003 contamination on the detection of single copy-number abnormalities in murine islet carcinomas by arrayCGH (Hodgson et al. 2001).”
BackgroundHackett, C. S., Hodgson, J. G., Law, M. E., Fridlyand, J., Osoegawa, K., de Jong, P. J., Nowak, N. J., Pinkel, D., Albertson, D. G., Jain, A. N., et al. (2003) · PubMed · Cited by 133
Self-citationConte, F., Fiscon, G., Chiara, M., Colombo, T., Farina, L., & Paci, P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171661 · Cited by 117
Slater, H. R., Bailey, D. K., Ren, H., Cao, M., Bell, K. M., Nasioulas, S., Henke, R., Choo, K. H. A., & Kennedy, G. C. (2005) · The American Journal of Human Genetics · doi:10.1086/497343 · Cited by 109
“Several limitations of these CGH arrays include the need for large amounts of starting material, resolution limited by the number of clones that can be deposited on the arrays, reagent variability from site to site, and lack of manufacturing standards; all of these constraints make it difficult for individual laborato…”
BackgroundInfluentialGreshock, J. D., Naylor, T. L., Margolin, A. A., Diskin, S. J., Cleaver, S. H., Futreal, P. A., deJong, P. J., Zhao, S., Liebman, M., & Weber, B. (2003) · Genome Research · doi:10.1101/gr.1847304 · Cited by 109
“Initial studies revealed the enormous potential of genomic copy number profiling using array-based comparative genomic hybridization (aCGH) as a tool for identifying candidate disease genes and cancer classification (Pinkel et al. 1998; Hodgson et al. 2001; Fritz et al. 2002; Pollack et al. 2002).”
BackgroundMethodInfluentialWakui, K., Gregato, G., Ballif, B. C., Glotzbach, C. D., Bailey, K. A., Kuo, P. L., Sue, W. C., Sheffield, L. J., Irons, M., Gómez, E. G., et al. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201366 · Cited by 112
Beheshti, B., Braude, I., Marrano, P. M., Thorner, P. S., Zieleńska, M., & Squire, J. A. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80017-9 · Cited by 105
“Although CGH studies using genomic DNA microarrays (BAC, PAC, cosmid) have recently been published [25–31], these arrays are not yet generally available and/or at present do not have sufficient genomic coverage and therefore resolution for screening.”
BackgroundGenome Amplification of Chromosome 20 in Breast Cancer
Hodgson, J., Chin, K., Collins, C. C., & Gray, J. W. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1023085825042 · Cited by 104
“Analyses of homogenously staining regions (HSRs), thought to be the cytological equivalent of amplified DNA, microdissected from breast cancer cell lines revealed amplified sequences from 20q11 [35].”
BackgroundInfluentialSelf-citationBayesian Hidden Markov Modeling of Array CGH Data
Guha, S., Li, Y., & Neuberg, D. S. (2008) · Journal of the American Statistical Association · doi:10.1198/016214507000000923 · Cited by 103
“Hodgson et al. (2001) used a normal mixture of three components to model the observed emissions. Olshen, Venkatraman, Lucito, and Wigler (2004) developed a variation of binary segmentation to identify chromosomal segments with altered copy numbers. Fridlyand, Snijders, Pinkel, Albertson, and Jain (2004) applied an uns…”
MethodInfluentialIdentification of homozygous deletions of tumor suppressor gene FAT in oral cancer using CGH-array
Nakaya, K., Yamagata, H. D., Arita, N., Nakashiro, K., Nose, M., Miki, T., & Hamakawa, H. (2007) · Oncogene · doi:10.1038/sj.onc.1210330 · Cited by 102
High‐resolution detection and mapping of genomic DNA alterations in neuroblastoma
Mossé, Y. P., Greshock, J. D., Margolin, A. A., Naylor, T. L., Cole, K. A., Khazi, D., Hii, G., Winter, C. L., Shahzad, S., Asziz, M. U., et al. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20198 · Cited by 102
“Array CGH is particularly amenable to analysis of cancer cells because it is relatively insensitive to normal cell contamination (Hodgson et al., 2001), and high-quality probes may be prepared from small amounts of archival material (Jain et al.”
Background[2] The Agilent In Situ‐Synthesized Microarray Platform
Wolber, P. K., Collins, P. J., Lucas, A. B., Witte, A. D., & Shannon, K. W. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)10002-6 · Cited by 102
Paris, P. L., Kobayashi, Y., Zhao, Q., Zeng, W., Sridharan, S., Fan, T. M., Adler, H. L., Yera, E. R., Zarrabi, M. H., Zucker, S., et al. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.12.007 · Cited by 105
“First, aCGH of tumor samples has been shown to allow up to 60% contaminating normal DNA while still providing accurate copy number information for the tumor [36].”
BackgroundPrice, T. S. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki643 · Cited by 92
“Other array CGH analytic approaches include the use of smoothing (18), 3-means clustering (19), estimating mixtures of Gaussian distributions (20,21) and hidden Markov models (HMMs) (22,23).”
MethodKitange, G. J., Misra, A., Law, M., Passe, S. M., Kollmeyer, T. M., Maurer, M. J., Ballman, K. V., Feuerstein, B. G., & Jenkins, R. B. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20108 · Cited by 90
“…hybridization (CGHa) (Beheshti et al., Snijders et al. 2001) is rapidly becoming a useful method for highresolution screening of genomewide aberrations (Hodgson et al., 2001; Aliferis et al., 2002; Cai et al., 2002; Ishizuka et al., 2002; Albertson, 2003; Clark et al., 2003; Veltman et al., 2003).”
MethodWorsham, M. J., Pals, G., Schouten, J. P., Miller, F. W., Tiwari, N., van Spaendonk, R. M. L., & Wolman, S. R. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9077-8 · Cited by 90
“MLPA provides high resolution relative quantitation of gene copy number at a much lower cost than array comparative genomic hybridization (CGH) with bacterial artificial chromosome (BAC) arrays [22, 26, 27], CGH with cDNA arrays [28,29], and spectral karyotyping (SKY) technologies [30].”
BackgroundWatson, J. E. V., Doggett, N. A., Albertson, D. G., Andaya, A., Chinnaiyan, A. M., van Dekken, H., Ginzinger, D. G., Haqq, C. M., James, K., Kamkar, S., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207474 · Cited by 91
Self-citationHereditary Hormone Excess: Genes, Molecular Pathways, and Syndromes
Marx, S. J., & Simonds, W. F. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0037 · Cited by 92
Du, Y. N., Lewis, B. C., Hanahan, D., & VARMUS, H. E. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050276 · Cited by 86
“It has been shown that the strain backgrounds influence the tumorigenesis of RIP-Tagmice, and the course of tumorigenesis is more consistent in a C57BL/6 background [16,17].”
BackgroundSelf-citationNetwork-Based Approaches to Explore Complex Biological Systems towards Network Medicine
Fiscon, G., Conte, F., Farina, L., & Paci, P. (2018) · Genes · doi:10.3390/genes9090437 · Cited by 89
Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis
Miyoshi, N., Ishii, H., Mimori, K., Takatsuno, Y., Kim, H., Hirose, H., Sekimoto, M., Doki, Y., & Mori, M. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605361 · Cited by 87
A Segmentation/Clustering Model for the Analysis of Array CGH Data
Picard, F., Robin, S. S., Lebarbier, É., & Daudin, J. J. (2007) · Biometrics · doi:10.1111/j.1541-0420.2006.00729.x · Cited by 83
“Note that the appropriateness of the Gaussian distribution for array CGH data has previously been demonstrated by Hodgson et al. (2001) when the noise is moderate.”
BackgroundThe role of Vitamin D3 metabolism in prostate cancer
Lou, Y., Qiao, S., Talonpoika, R., Syvälä, H., & Tuohimaa, P. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.10.007 · Cited by 82
Adams, D. C., Larman, B. W., & Oxburgh, L. H. (2006) · Gene Expression Patterns · doi:10.1016/j.modgep.2006.10.009 · Cited by 82
“, 1997), and has been identified as a potential tumor suppressor (Hodgson et al., 2001).”
BackgroundThe Role of p53 in Suppression of KSHV Cyclin-induced Lymphomagenesis
Verschuren, E. W., Hodgson, J., Gray, J. W., Kogan, S. C., Jones, N., & Evan, G. I. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1863 · Cited by 86
Self-citationFollistatin‐like 1 in vertebrate development
Sylva, M., Moorman, A. F. M., & van den Hoff, M. J. B. (2013) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.21030 · Cited by 84
Search for unknown tumor‐antagonizing genes
Imreh, S., Klein, G., & Zabarovsky, E. R. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10271 · Cited by 78
“A recent microarray CGH analysis has shown that the LOH9 region (that is syntenic with a 3q region) is equally frequently lost in these insulinomas as the CER1 markers (D9Mit152 and D9Mit52) (Hodgson et al., 2001 and http.//shark.ucsf.edu:8080/graeme/ Nat_Gen_2001.html).”
BackgroundA fast and flexible method for the segmentation of aCGH data
Ben-Yaacov, E., & Eldar, Y. C. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn272 · Cited by 83
“A simple suggestion is to consider all segments with values outside m times the standard deviation range to be aberrant (Hodgson et al., 2001), where m is frequently set to three. An iterative method based on nonparametric statistical tests called MergeLevels was suggested in Willenbrock and Fridlyand (2005). Tibshira…”
MethodArray Comparative Genomic Hybridization Identifies Genetic Subgroups in Grade 4 Human Astrocytoma
Misra, A., Pellarin, M., Nigro, J. M., Smirnov, I. V., Moore, D. H., Lamborn, K. R., Pinkel, D., Albertson, D. G., & Feuerstein, B. G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0708 · Cited by 73
Self-citationThe Mouse Tumor Biology database
Krupke, D. M., Begley, D. A., Sundberg, J. P., Bult, C. J., & Eppig, J. T. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2390 · Cited by 75
Moore, L. E., Jaeger, E., Nickerson, M. L., Brennan, P., Vries, S. D., Roy, R., Toro, J. R., Li, H., Karami, S., Lenz, P., et al. (2012) · Oncogenesis · doi:10.1038/oncsis.2012.14 · Cited by 82
Mapping segmental and sequence variations among laboratory mice using BAC array CGH
Snijders, A. M., Nowak, N. J., Huey, B., Fridlyand, J., Law, S., Conroy, J., Tokuyasu, T., Demir, K., Chiu, R., Mao, J.-H., et al. (2005) · Genome Research · doi:10.1101/gr.2902505 · Cited by 72
“…markers as described previously (Cheung et al. 2001) and (2) by identifying BACs with particular STS markers using published information (Cai et al. 1998; Hodgson et al. 2001) or information from the mouse genome sequencing program as the sequencing and radiation hybrid mapping projects progressed.”
BackgroundSelf-citationHong, C., Maunakea, A. K., Jun, P., Bollen, A. W., Hodgson, J., Goldenberg, D., Weiss, W. A., & Costello, J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0048 · Cited by 71
Ionizing radiation induces heritable disruption of epithelial cell interactions
Park, C. C., Henshall-Powell, R. L., Erickson, A. C., Talhouk, R., Parvin, B., Bissell, M. J., & Barcellos-Hoff, M. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1832185100 · Cited by 70
Detection of gene copy number changes in CGH microarrays using a spatially correlated mixture model
Broët, P., & Richardson, S. T. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl035 · Cited by 78
Horvai, A., DeVries, S., Roy, R., O’Donnell, R. J., & Waldman, F. M. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.119 · Cited by 69
Genome-Wide Array-Based Comparative Genomic Hybridization of Diffuse Large B-Cell Lymphoma
Tagawa, H., Tsuzuki, S., Suzuki, R., Karnan, S., Ota, A., Kameoka, Y., Suguro, M., Matsuo, K., Yamaguchi, M., Okamoto, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-4056 · Cited by 72
Metadata
- Authors
- Hodgson, G., Hager, J. H., Volik, S., Hariono, S., Wernick, M., Moore, D., Albertson, D. G., Pinkel, D., Collins, C., Hanahan, D., & Gray, J. W.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Gray, Joe W.
- Venue
- Nature Genetics
- Published
- 2001-11-05
- Volume
- 29
- Issue
- 4
- Pages
- 459-464
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1520880567
- Cited by
- 294
- References
- 26
- Citations by year
- 2024: 6 · 2023: 1 · 2021: 1 · 2020: 2 · 2018: 3 · 2017: 4 · 2016: 5 · 2015: 7 · 2014: 10 · 2013: 3 · 2012: 5
- FWCI
- 15.83
- Type
- journal article
- Language
- en
- Update notices
- correction (2001-12-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ca078601-02)
- U.S. Public Health Service
- University of California, San Francisco
- National Cancer Institute (CA82103, R37-CA45234, CA78601, P30CA082103, R37CA045234)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Keywords
- SV40 T antigen, loss of heterozygosity, chromosome 9, chromosome 16, copy number alterations, array comparative genomic hybridization, tumor suppressor, oncogenes, CYP24, STMN1, p27, FSTL1, genetic background, irradiation, mouse tumor model
- MeSH terms
- Animals, Base Sequence, Humans, Islets of Langerhans, Mice, Transgenic, Nucleic Acid Hybridization, Pancreatic Neoplasms, Genome, DNA Primers, Loss of Heterozygosity, Oligonucleotide Array Sequence Analysis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.